Latest StemPoint Capital LP Stock Portfolio
StemPoint Capital LP Performance:
2024 Q4: -5.12%YTD: 8.11%
Performance for 2024 Q4 is -5.12%, and YTD is 8.11%.
About StemPoint Capital LP and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, STEMPOINT CAPITAL LP reported an equity portfolio of $400.6 Millions as of 31 Dec, 2024.
The top stock holdings of STEMPOINT CAPITAL LP are SNDX, ROIV, IMVT. The fund has invested 9.5% of it's portfolio in SYNDAX PHARMACEUTICALS INC and 8% of portfolio in ROIVANT SCIENCES LTD.
The fund managers got completely rid off AMICUS THERAPEUTICS INC (FOLD), AUTOLUS THERAPEUTICS PLC (AUTL) and DAY ONE BIOPHARMACEUTICALS I (DAWN) stocks. They significantly reduced their stock positions in ARCUTIS BIOTHERAPEUTICS INC (ARQT), PROTARA THERAPEUTICS INC (TARA) and BRISTOL-MYERS SQUIBB CO (BMY). STEMPOINT CAPITAL LP opened new stock positions in XENON PHARMACEUTICALS INC (XENE), NUVALENT INC (NUVL) and KALVISTA PHARMACEUTICALS INC (KALV). The fund showed a lot of confidence in some stocks as they added substantially to REVOLUTION MEDICINES INC (RVMD), ALKERMES PLC (ALKS) and CENTESSA PHARMACEUTICALS PLC (CNTA).
The top stock holdings of STEMPOINT CAPITAL LP are SNDX, ROIV, IMVT. The fund has invested 9.5% of it's portfolio in SYNDAX PHARMACEUTICALS INC and 8% of portfolio in ROIVANT SCIENCES LTD.
The fund managers got completely rid off AMICUS THERAPEUTICS INC (FOLD), AUTOLUS THERAPEUTICS PLC (AUTL) and DAY ONE BIOPHARMACEUTICALS I (DAWN) stocks. They significantly reduced their stock positions in ARCUTIS BIOTHERAPEUTICS INC (ARQT), PROTARA THERAPEUTICS INC (TARA) and BRISTOL-MYERS SQUIBB CO (BMY). STEMPOINT CAPITAL LP opened new stock positions in XENON PHARMACEUTICALS INC (XENE), NUVALENT INC (NUVL) and KALVISTA PHARMACEUTICALS INC (KALV). The fund showed a lot of confidence in some stocks as they added substantially to REVOLUTION MEDICINES INC (RVMD), ALKERMES PLC (ALKS) and CENTESSA PHARMACEUTICALS PLC (CNTA).
StemPoint Capital LP Annual Return Estimates Vs S&P 500
Our best estimate is that STEMPOINT CAPITAL LP made a return of -5.12% in the last quarter. In trailing 12 months, it's portfolio return was 8.11%.
New Buys
| Ticker | $ Bought |
|---|---|
| xenon pharmaceuticals inc | 14,733,100 |
| nuvalent inc | 11,368,900 |
| kalvista pharmaceuticals inc | 8,409,040 |
| insmed inc | 7,360,350 |
| scholar rock hldg corp | 7,187,790 |
| iovance biotherapeutics inc | 7,025,570 |
| biontech se | 6,996,870 |
| protagonist therapeutics inc | 5,470,160 |
New stocks bought by StemPoint Capital LP
Additions
Additions to existing portfolio by StemPoint Capital LP
Reductions
| Ticker | % Reduced |
|---|---|
| arcutis biotherapeutics inc | -71.83 |
| protara therapeutics inc | -64.75 |
| bristol-myers squibb co | -39.68 |
| praxis precision medicines i | -22.9 |
| biohaven ltd | -13.87 |
| roivant sciences ltd | -2.06 |
StemPoint Capital LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| autolus therapeutics plc | -9,498,260 |
| amicus therapeutics inc | -15,825,700 |
| cabaletta bio inc | -6,034,260 |
| zura bio ltd | -4,239,320 |
| tscan therapeutics inc | -4,287,540 |
| pyxis oncology inc | -3,120,270 |
| vigil neuroscience inc | -2,528,640 |
| day one biopharmaceuticals i | -7,062,200 |
StemPoint Capital LP got rid off the above stocks
Sector Distribution
STEMPOINT CAPITAL LP has about 88.1% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 88.1 |
| Others | 11.9 |
Market Cap. Distribution
STEMPOINT CAPITAL LP has about 7.6% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MID-CAP | 50.6 |
| SMALL-CAP | 27 |
| UNALLOCATED | 11.9 |
| LARGE-CAP | 7.6 |
| NANO-CAP | 1.7 |
| MICRO-CAP | 1.2 |
Stocks belong to which Index?
About 59.8% of the stocks held by STEMPOINT CAPITAL LP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 54.1 |
| Others | 40.1 |
| S&P 500 | 5.7 |
StemPoint Capital LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of StemPoint Capital LP
STEMPOINT CAPITAL LP has 48 stocks in it's portfolio. About 50.8% of the portfolio is in top 10 stocks. SNDX proved to be the most loss making stock for the portfolio. ARQT was the most profitable stock for STEMPOINT CAPITAL LP last quarter.
Last Reported on: 14 Feb, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ACLX | arcellx inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ALKS | alkermes plc | 2.99 | 416,968 | 11,992,000 | added | 752 | ||
| ARQT | arcutis biotherapeutics inc | 1.74 | 500,966 | 6,978,460 | reduced | -71.83 | ||
| ATXS | astria therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AUTL | autolus therapeutics plc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BBIO | bridgebio pharma inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BMY | bristol-myers squibb co | 2.35 | 166,068 | 9,392,810 | reduced | -39.68 | ||
| CABA | cabaletta bio inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CAPR | capricor therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CDTX | cidara therapeutics inc | 0.32 | 47,642 | 1,280,620 | new | |||
| CNTA | centessa pharmaceuticals plc | 2.68 | 641,964 | 10,752,900 | added | 667 | ||
| CRNX | crinetics pharmaceuticals in | 4.05 | 317,060 | 16,211,300 | added | 48.29 | ||
| CYTK | cytokinetics inc | 0.98 | 83,576 | 3,931,420 | added | 477 | ||
| DAWN | day one biopharmaceuticals i | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| DNLI | denali therapeutics inc | 2.97 | 584,328 | 11,908,600 | added | 107 | ||
| ETNB | 89bio inc | 1.06 | 545,800 | 4,268,160 | new | |||
| EWTX | edgewise therapeutics inc | 0.88 | 132,706 | 3,543,250 | added | 566 | ||
| EYPT | eyepoint pharmaceuticals inc | 1.08 | 579,500 | 4,317,280 | new | |||
| FOLD | amicus therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| IDYA | ideaya biosciences inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||